MENU×

AMPYRA Patient Support Services (APSS): Your Connection to AMPYRA® (dalfampridine) Coverage

Improved walking is important. So is having support for AMPYRA® (dalfampridine) Extended Release Tablets, 10 mg, insurance coverage, and help with the out-of-pocket cost of medication.

We created APSS to make getting AMPYRA as simple as possible for people who are eligible.

AMPYRA Insurance Coverage & Co-pay Assistance

If you are prescribed AMPYRA, APSS can confirm whether your insurance will cover your prescription, and whether you are eligible* for our co-pay assistance program. If you have commercial insurance (employer-sponsored or individual) and AMPYRA is covered, you may be eligible for co-pay assistance for AMPYRA where allowed by law.

This co-pay assistance may lower the amount you pay for your AMPYRA prescription to as little as $10 for a monthly prescription or $30 for a 3-month prescription.

*Patients who participate in Medicaid, Medicare, or any other federal healthcare program are not eligible to receive co-pay assistance.

Co-pay assistance is provided up to $1,000 per month per person, with a $12,000 annual maximum.

Access when you need it

Taking AMPYRA is an important step. We're here to provide personalized service and help you every step of the way.

Want to learn more? You can reach APSS toll-free at 1-888-881-1918, Monday through Friday, from 8 AM to 8 PM Eastern Time.

Indication

AMPYRA® (dalfampridine) Extended Release Tablets, 10 mg, is the first and only brand prescription medicine indicated to help improve walking in adults with multiple sclerosis (MS). This was demonstrated by an increase in walking speed.

Important Safety Information

Do not take AMPYRA if you have ever had a seizure, have certain types of kidney problems, or are allergic to dalfampridine (4-aminopyridine), the active ingredient in AMPYRA.

Indication & Important Safety Information

INDICATION

AMPYRA® (dalfampridine) Extended Release Tablets, 10 mg, is the first and only brand prescription medicine indicated to help improve walking in adults with multiple sclerosis (MS). This was demonstrated by an increase in walking speed.

IMPORTANT SAFETY INFORMATION

Do not take AMPYRA if you:

  • have ever had a seizure,
  • have certain types of kidney problems, or
  • are allergic to dalfampridine (4-aminopyridine), the active ingredient in AMPYRA.

Take AMPYRA exactly as prescribed by your doctor.

Before taking AMPYRA, tell your doctor if you:

  • have kidney problems or any other medical conditions
  • are taking compounded 4-aminopyridine
  • are taking any other prescription or OTC medicines, such as cimetidine
  • are pregnant or plan to become pregnant. It is not known if AMPYRA will harm your unborn baby.
  • are breast-feeding or plan to breast-feed. It is not known if AMPYRA passes into your breast milk. You and your doctor should decide if you will take AMPYRA or breast-feed. You should not do both.

Stop taking AMPYRA and call your doctor right away if you have a seizure while taking AMPYRA. You could have a seizure even if you never had a seizure before. Your chance of having a seizure is higher if you take too much AMPYRA or if your kidneys have a mild decrease of function, which is common after age 50. Your doctor may do a blood test to check how well your kidneys are working before you start AMPYRA.

AMPYRA should not be taken with other forms of 4-aminopyridine (4-AP, fampridine), since the active ingredient is the same.

AMPYRA may cause serious side effects, including severe allergic reactions. Stop taking AMPYRA and call your doctor right away or get emergency medical help if you have shortness of breath or trouble breathing, swelling of your throat or tongue, or hives.

The most common side effects for AMPYRA in MS patients were urinary tract infection; trouble sleeping; dizziness; headache; nausea; weakness; back pain; problems with balance; multiple sclerosis relapse; burning, tingling, or itching of your skin; irritation in your nose and throat; constipation; indigestion; and pain in your throat.

Please see the Patient Medication Guide.